Omega Fund Management, LLC
- SEC CIK
- 0001637359
- Latest filing
- Aug 14, 2026
Holdings in Q2 2023
Holdings as of Jun 30, 2023, filed Aug 14, 2023. Long positions only; changes compare share counts with Q1 2023.
- Positions
- 12
- −2 vs. Q1 2023
- Portfolio value
- $178.5M
- +$25.2M (+16.4%) vs. Q1 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| REPLReplimune Group, Inc. | COM | 3,001,319 | $69.7M | 39.0% | −48,868−1.6% | Reduced | History |
| NUVBNuvation Bio Inc. | COM CL A | 15,072,340 | $27.1M | 15.2% | 00.0% | Unchanged | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 2,029,580 | $20.9M | 11.7% | 00.0% | Unchanged | History |
| MORFMorphic Holding, Inc. | COM | 309,846 | $17.8M | 10.0% | −287,877−48.2% | Reduced | History |
| IMAImageneBio, Inc. | COM | 2,249,123 | $14.8M | 8.3% | 00.0% | Unchanged | History |
| THRXTheseus Pharmaceuticals, Inc. | COM | 711,479 | $6.64M | 3.7% | 00.0% | Unchanged | History |
| KRONKronos Bio, Inc. | COM | 3,818,283 | $6.57M | 3.7% | 00.0% | Unchanged | History |
| SANASana Biotechnology, Inc. | COM | 843,750 | $5.03M | 2.8% | 00.0% | Unchanged | History |
| SPRBSpruce Biosciences, Inc. | COM | 2,161,022 | $4.65M | 2.6% | 00.0% | Unchanged | History |
| IMUXImmunic, Inc. | COM | 1,788,160 | $4.49M | 2.5% | 00.0% | Unchanged | History |
| SYRSSyros Pharmaceuticals, Inc. | COM NEW | 251,270 | $791.5K | 0.4% | 00.0% | Unchanged | History |
| SNTISenti Biosciences Holdings, Inc. | COM | 195,792 | $122.8K | 0.1% | 00.0% | Unchanged | History |
Sold out since Q1 2023 (2)
Positions held at the end of Q1 2023 that are gone from this filing.